Enfusion, Inc.
Enfusion, Inc.（ENFN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
enfn · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2025年11月18日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Hold
8 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $10.76
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $10.69 | ↓ 0.62% |
1-day model range: $10.67–$10.72. Peak: $10.72 (-0.62%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $11 | +0.8% |
| 2028 | $11 | +1.3% |
| 2029 | $11 | +1.5% |
| 2030 | $11 | +1.6% |
| 2031 | — | +1.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ENFN · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-01-13 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2024-12-23 | Piper Sandler | Maintains | Neutral→Neutral |
| 2024-12-18 | Stifel | Maintains | Buy→Buy |
| 2024-03-13 | B of A Securities | Maintains | Underperform→Underperform |
| 2024-02-28 | Goldman Sachs | Downgrade ↓ | Neutral→Sell |
| 2024-01-30 | JP Morgan | Downgrade ↓ | Neutral→Underweight |
| 2023-12-20 | Piper Sandler | Maintains | Neutral→Neutral |
| 2023-08-09 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2023-08-09 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2023-08-08 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Enfusion, Inc. (ENFN) stock. Of the recent 49 rating actions, 2 were upgrades and 7 were downgrades. 8 analysts currently cover ENFN.
分析师推荐趋势
ENFN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$188M
↓ 20.6% YoY
Revenue Next Year
$203M
↑ 7.7% YoY
EPS This Year
$0.04
EPS Next Year
$0.21
↑ 498.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast ENFN EPS of $0.04 for the current fiscal year, based on estimates from 4 analysts. The ENFN revenue forecast is $188M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ENFN 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ENFN 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。
ENFN 的短期预测（明日）为 $10.69（-0.62%）。 ENFN 对 2027 年的股价预测均值为 $11。 ENFN 对 2030 年的预测区间为 $11–$11。
Enfusion, Inc. 在 NYSE 上市，代码 ENFN。ENFN 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 25% 对应 Hold 共识。
常见问题
ENFN 预测 · 8 个问题根据 8 位华尔街分析师，ENFN 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $10.76，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.